Post by
DJDawg on Dec 14, 2021 12:26pm
Interesting perspective
Hi
I had mentioned this company to a friend, whose husband is a type A kind of research person and it was interesting hear his perspective.
His concerns were as follows:
- penny stock price that his highly volatile in price.
- a glass door employee rating from 2017 that mentioned a dysfunctional workplace where the husband and wife owners have loud disagreements all the time. And who micromanage everything without realizing that they don't know everything.
- rapid CEO changeover (2 in the past 6 months alone)
- analyst ratings as a "speculative" play
He said it seems like a terrible idea to invest.
I found it fascinating as I completely agree. Everything I've read sounds like the leadership issues are big. It is speculative to a degree. The CEO changeover issues don't inspire faith at all.
I guess my only personal faith is that no matter how badly run the company is, if they are recruiting patients via the supporting centres, giving them the drug at a good dose and procedure at a good dose, that is what counts. Thankfully we are not relying on RDW's word regarding the medical results as those are controlled by the academic urologists rather than the corporate leadership. I have faith in some of the names on the med adv board and have faith in Vera and her background.
But overall, I can totally see why so many people will stay away a bit longer. Need the BTD to breakout I think.
Just in interesing perspective from my friend's husband. Thought I would share.
DJ
Comment by
floatinketucky on Dec 14, 2021 12:41pm
And did what did they conclude of the science? Like the CR rates? The BTD? Like the phase 2 trial being PIVITOL? The actual buisness/SCIENCE of the company?
Comment by
menoalittle on Dec 14, 2021 12:43pm
>> The actual buisness/SCIENCE of the company? In short, it's simply not understood well enough to be believable to most people.
Comment by
floatinketucky on Dec 14, 2021 12:45pm
Like who cares about the paint job, Can the vehicle get to the next buisness goal? The science seems clearly to be showing it very very likely. I thinik this is a good truck.
Comment by
fredgoodwinson on Dec 14, 2021 1:34pm
Here primarily for what x-ray activated Rutherrin may do against deep cancers but in addition to NMIBC there are many superficial cancers with less than satisfactory outcomes for which TLD-1433 may prove suitable. Difficult to reconcile the thin-ness of the buy side at these modest levels with the Clinical data from the last Newsletter but continue to add.
Comment by
menoalittle on Dec 14, 2021 1:46pm
>> Difficult to reconcile the thin-ness of the buy side at these modest levels it's because everything between 20 and 35 cents has already vacuumed up. only mere tidbits remain... (until the next 15 cent step up.)
Comment by
robertshaw on Dec 14, 2021 1:57pm
count on blowjobjoe's bosses selling more cheapies...
Comment by
menoalittle on Dec 14, 2021 2:18pm
>> count on blowjobjoe's bosses selling more cheapies... well... what are they waiting for? Christmas ?
Comment by
robertshaw on Dec 15, 2021 12:22pm
Here comes the Blowjobjoe's bosses' dumping as we expected.., But I guess less long shareholders dare to buy now as brave guys like Lesalpes29 and Sunvalley just did...
Comment by
floatinketucky on Dec 15, 2021 12:55pm
If the stock maintains a quarter or so by the next release...
Comment by
fredgoodwinson on Dec 14, 2021 2:28pm
TBH with the way they twist the market find that less surprising than there being only 1500 on the bid at 33.5,
Comment by
menoalittle on Dec 14, 2021 2:34pm
ya, well... try not to be fooled by that wee little (iceberg's) size. I've seen 'em able to swallow a river.
Comment by
floatinketucky on Dec 14, 2021 5:11pm
I expect a move to .50 cents+ will be brought on more by price discovry individual investers rather than professionaly advised investers.